查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球動物腸道健康市場-2022-2029
市場調查報告書
商品編碼
1129257

全球動物腸道健康市場-2022-2029

Global Animal Intestinal Health Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

預計動物腸道健康意識的提高將推動市場增長。

全球動物保健公司奧特奇為畜禽養殖戶提供有機營養補充劑。該公司以腸道健康為重點，建立了“全技術抗生素減少計劃”，以生產始終健康的動物並減少預防性和準抗生素的使用。該計劃幫助奶農制定行動計劃。該計劃適用於希望採取行動改善畜群和綿羊健康的牲畜所有者。一組專家為生產者提供建議和指導。奧特奇腸道健康平台的行業顧問、獸醫和營養師通過制定定制的行動計劃和提供支持來幫助種植者減少農場的抗生素使用。例如，在英國的一個養豬場，奧特奇的抗生素減少計劃得到了全面實施。因此，農民和動物生產者的意識不斷增強，增加了對動物腸道健康補充劑的需求。因此，從上述陳述來看，預計市場將在預測期內受到驅動。

約束

與用於腸道健康的飼料添加劑相關的價格上漲、用於開發非抗生素生長促進劑的活性成分成本上漲以及對各種飼料添加劑的嚴格監管 在預測期內，預計有幾個因素會阻礙市場.

行業分析

動物腸道健康市場基於供應鏈分析、價格分析等各種行業因素對市場進行了深入分析。

COVID-19 影響分析

COVID-19 大流行對市場產生了適度的影響。 COVID-19 流行期間的交通限制和其他社會排斥因素大大減少了動物供應和生產力。 COVID的最初影響引發了恐慌性購買並增加了肉類和奶製品的銷售。因此，大流行將擾亂牛產品的供應鍊和流程。許多公司轉移到其他地區以維持產品供應並保護其供應鏈。因此，從上面這句話來看，市場受到了影響，預計隨著經濟活動的恢復，市場將迅速獲得牽引力。

全球動物腸道健康市場報告提供大約 45 多個市場數據表、40 多個數字和 180 頁內容。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因子
    • 驅動程序
      • 預計動物腸道健康意識的提高將推動市場增長。
    • 限制因素
      • 用於腸道健康的飼料添加劑價格上漲預計將阻礙市場增長。
    • 機會
    • 影響分析

第五章行業分析

  • 供應鏈分析
  • 定價分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章通過飼養動物

  • 水產養殖
  • 家禽
  • 反芻動物
  • 豬
  • 其他

第 8 章來源

  • 微生物來源
  • 植物來源

第 9 章形態學

  • 烘乾
  • 液體
  • 其他

第 10 章添加劑

  • 益生菌
  • 益生元
  • 免疫刺激劑
  • 植物性
  • 其他

第 11 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 12 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準
  • 值得關注的重點公司列表

第 13 章公司簡介

  • AB Vista
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Nutrition & Biosciences
  • Kemin Industries, Inc.
  • Lesaffre
  • Adisseo
  • Cargill, Incorporated
  • Evonik Industries
  • Novozymes
  • Pure Cultures
  • Chr. Hansen Holdings

第 14 章全球動物腸道健康市場-DataM

簡介目錄
Product Code: DMVH5845

Market Overview

Animal Intestinal Health Market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Animal intestinal health defines gut health as physiological and functional elements, such as nutrition digestion and absorption, host metabolism and energy production, a stable and functional microbiota/microbiome, defensive systems, and the interactions between these elements. Good health is a prerequisite for any animal to fulfill its genetic potential. The connections to daily increases, regularity, and feed conversion are obvious. Diet has a bearing on health, especially regarding reducing risks and curing disorders. Animal husbandry can impact one's health almost any way, and animal nutrition is no exception.

Market Dynamics

Rising awareness regarding animals' intestinal health is expected to drive market growth.

Global animal health company Alltech offers organic dietary supplements to farmers raising livestock and poultry. By putting a strong emphasis on gut health, the company has established an Alltech Antibiotic Reduction program to produce consistently healthy animals and decrease prophylactic and metaphylactic antibiotic use. The program can help the farmer create an action plan. This program is for livestock owners who are dedicated to taking action to improve the health of their herd or flock. A group of professionals advises and mentor the producer. The Alltech Gut Health Platform's industry advisors, veterinarians, and nutritionists support producers in reducing farm antibiotic use by developing a customized action plan and offering support. For instance, The full Alltech Antibiotic Reduction program was implemented on a pig farm in the United Kingdom. Therefore, increasing awareness among farmers and animal producers has increased the demand for animal intestinal health supplements. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint

Increasing prices associated with feed additives utilized for intestinal health, rising expense of active ingredients used in the development of non-antibiotic growth promoters, and stringent regulations regarding different feed additives are some factors the market is expected to get hampered in the forecast period.

Industry Analysis

The animal intestinal health market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted the market. Due to transportation limitations and other social exclusionary factors during the COVID-19 epidemic, animal supplies and productivity drastically decreased. The first impact of COVID led to panic buying, which increased sales of meat and dairy products. Therefore, the pandemic interrupts the supply chain and process for cattle products. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Probiotics segment is expected to hold the largest market share in animal intestinal health market

The probiotics segment is expected to dominate in 2021. Probiotics make up a sizable portion of the feed supplements utilized in the cattle business. When properly ingested, probiotics, which are microbial feed supplements, help the host's health. Fish and animals may develop healthier and more rapidly with the help of probiotics. It also aids in speeding up an animal's digestion. It is being utilized more frequently to improve cattle performance as a safe and effective substitute for antibiotics. Animal growth, immunological response, nutrient digestibility and absorption, gut microbiota composition, and meat quality were all improved by probiotics.

Moreover, more significant research describing particular strains, determining the ideal dosage, and comprehending the network of interactions between probiotics and the gut microbiota may aid in creating probiotic mixes for animal feed and meat products that are more successful. Farm animals treated with probiotics had lower morbidity and vitality, improved eating habits, and produced more. Additionally, their application has expanded in the food business due to probiotics' capacity to suppress a wide variety of harmful bacteria. Probiotic supplements also contributed to the increase in broiler chicken body weight. Therefore, it has increased the demand for probiotics. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global animal intestinal health market

In 2021, North America accounted for the highest revenue share. Increasing consumption of meat and dairy products, growing livestock count and the associated animal feed required for the healthy maintenance of the livestock and product launches by the region's key market players are some factors the market is expected to boost in the forecast period. For instance, According to the United States Department of Agriculture Economic Research Service, the country produced more than 2,26,258 million pounds of milk in 2021. Moreover, to feed the gastrointestinal tract in calves, optimize average daily gains, support calf immune system development, and reinforce a healthy gut microbiome without using antibiotics at any stage of production, Alltech released Bio-Mos 2 as a second-generation feed additive in April 2022. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the animal intestinal health market are AB Vista, Nutrition & Biosciences, Kemin Industries, Inc., Lesaffre, Adisseo, Cargill, Incorporated, Evonik Industries, Novozymes, Pure Cultures, Chr. Hansen Holdings.

Kemin Industries, Inc.:

Overview:

Kemin was established in 1961 and headquartered in Des Moines, Iowa. It offers molecules that have been specially created to assist both human and animal health and nutrition. The company is dedicated to the safety of food and feed. It maintains production facilities where specialized ingredients are created for the food and feed industries and the health, nutrition, and beauty sectors. Moreover, the business involves pharma, food technologies, nutrisurance, and personal care.

Product Portfolio:

COZANTE: A patented polyphenol from plants called COZANTE is used to help chicken farms reduce Eimeria species. Its active component is delivered using Kemin's unique spray freezing technology (SFT) of encapsulation. This procedure will deliver the active substance evenly along the gut length.

The global animal intestinal health market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising awareness regarding animals' intestinal health is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. Increasing prices associated with feed additives utilized for intestinal health is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Live Stock

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 7.1.2. Market Attractiveness Index, By Live Stock Segment
  • 7.2. Aquaculture*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Poultry
  • 7.4. Ruminant
  • 7.5. Swine
  • 7.6. Others

8. By Source

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 8.1.2. Market Attractiveness Index, By Source Segment
  • 8.2. Microbial*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Plant Based

9. By Form

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 9.1.2. Market Attractiveness Index, By Form Segment
  • 9.2. Dry*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Liquid
  • 9.4. Others

10. By Additive

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive
    • 10.1.2. Market Attractiveness Index, By Additive Segment
  • 10.2. Probiotics*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Prebiotics
  • 10.4. Immunostimulants
  • 10.5. Phytogenics
  • 10.6. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Live Stock
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Additive

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. AB Vista*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Nutrition & Biosciences
  • 13.3. Kemin Industries, Inc.
  • 13.4. Lesaffre
  • 13.5. Adisseo
  • 13.6. Cargill, Incorporated
  • 13.7. Evonik Industries
  • 13.8. Novozymes
  • 13.9. Pure Cultures
  • 13.10. Chr. Hansen Holdings

LIST NOT EXHAUSTIVE

14. Global Animal Intestinal Health Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us